You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 22, 2011

Clemence Gautier to Speak on Clinical Trials

Subscribe to Updates

On May 20, 2011, Clemence Gautier, Consultant, Intellectual Property, will speak at what has been billed as the most comprehensive forum on clinical trials in Thailand. Clinical Trial Forum Thailand 2011 aims to assemble key opinion leaders from the government, research institutes, service providers, originators, and other stakeholders to discuss contemporary challenges in the Thailand market.

Clemence Gautier will present on “Overcoming Regulatory and Patent Roadblocks for Clinical Trials in Asia: Thailand and Vietnam,” which will provide practical tips for ensuring smooth clinical trials in Thailand, from both a regulatory and a contractual perspective. For more information on Clinical Trial Forum Thailand 2011, access the Lawson-Marsh website.

RELATED PROFESSIONAL

Industries

Life Sciences

Practices

Intellectual Property

Regulatory Affairs

Location

RELATED INSIGHTS​ 

January 8, 2013
Leading Southeast Asian regional law firm Tilleke & Gibbins has promoted four attorneys to the firm’s partnership, effective January 2013.Coming from across the major practice groups in the firm’s Bangkok office, the new partners include Charunun Sathitsuksomboon and Kobkit Thienpreecha of the firm’s corporate and commercial group, Chusert Supasitthumrong of the dispute resolution department, and Sukontip Jitmongkolthong of the intellectual property team.
Read More
October 12, 2012
On November 22, 2012, the Euromoney Legal Media Group will hold its second annual Asia Women in Business Law Awards at the Renaissance Harbour View Hotel in Hong Kong. Again this year, Tilleke & Gibbins stands amongst a leading group of law firms that will be recognized for their commitment to the advancement of women. The firms will be judged on a range of factors, predominately initiatives for gender diversity, innovation, mentoring, talent management, and female leadership within each firm.
Read More
September 5, 2012
Starting October 1, 2012, overseas pharmaceutical manufacturers that have never before been recorded in the Drug Product Registry of Thailand will need to be accredited by the Thai Food and Drug Administration (FDA) before marketing authorization can be obtained. Otherwise, the FDA will not allow the business operator to submit an Application for Importation of Drug Product Sample, which is a required document for drug product registration.
Read More